The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Richard Moreau

INSERM

U773, Centre de Recherche Biomédicale Bichat-Beaujon CRB3

and Service d'Hépatologie

France

[email]@*.inserm.fr

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • INSERM, U773, Centre de Recherche Biomédicale Bichat-Beaujon CRB3, and Service d'Hépatologie, France. 2006 - 2007
  • Service d'Hépatologie and INSERM Unité 481, Hôpital Beaujon, Clichy, France. 2004 - 2006
  • Laboratoire d'Hémodynamique Splanchnique et de Biologie Vasculaire, INSERM U-481, Clichy, France. 2002 - 2003

References

  1. Diagnosis and treatment of acute renal failure in patients with cirrhosis. Moreau, R., Lebrec, D. Best. Pract. Res. Clin. Gastroenterol (2007) [Pubmed]
  2. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail. Moreau, R., Valla, D.C., Durand-Zaleski, I., Bronowicki, J.P., Durand, F., Chaput, J.C., Dadamessi, I., Silvain, C., Bonny, C., Oberti, F., Gournay, J., Lebrec, D., Grouin, J.M., Guémas, E., Golly, D., Padrazzi, B., Tellier, Z. Liver Int. (2006) [Pubmed]
  3. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond. Moreau, R., Lebrec, D. Hepatology (2006) [Pubmed]
  4. Molecular and structural basis of portal hypertension. Moreau, R., Lebrec, D. Clin. Liver. Dis (2006) [Pubmed]
  5. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites. Moreau, R., Delègue, P., Pessione, F., Hillaire, S., Durand, F., Lebrec, D., Valla, D.C. Liver Int. (2004) [Pubmed]
  6. Acute renal failure in patients with cirrhosis: perspectives in the age of MELD. Moreau, R., Lebrec, D. Hepatology (2003) [Pubmed]
  7. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study. Moreau, R., Asselah, T., Condat, B., de Kerguenec, C., Pessione, F., Bernard, B., Poynard, T., Binn, M., Grangé, J.D., Valla, D., Lebrec, D. Gut (2002) [Pubmed]
  8. Hepatorenal syndrome in patients with cirrhosis. Moreau, R. J. Gastroenterol. Hepatol. (2002) [Pubmed]
  9. Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis. Moreau, R., Barrière, E., Tazi, K.A., Lardeux, B., Dargère, D., Urbanowicz, W., Poirel, O., Chauvelot-Moachon, L., Guimont, M.C., Bernuau, D., Lebrec, D. Hepatology (2002) [Pubmed]
 
WikiGenes - Universities